Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Obstetric outcomes of women who continued or stopped their biosimilar DMARD in pregnancy.
| Continued biosimilar (n = 7) | Stopped biosimilar (n = 11) | ||
|---|---|---|---|
| Flare in pregnancy/early post-partum | 2 | 7 | ns |
| Gestation at delivery, weeks+days | 39+5 (38+5–41+1) | 38+5 (36+6–39+5) | p = 0.02 |
| Mode of delivery | |||
| Vaginal delivery | 4 | 3 | ns |
| Elective caesarean section | 3 | 7 | ns |
| Emergency caesarean section | 0 | 1 | ns |
| Birthweight, g (±SEM) | 3257 (±141) | 3200 (±171) | ns |
| Birthweight centile, mean (range) | 31 (5–59) | 36 (4–95) | ns |
